NCT03473574
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
- Locations
-
- Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie & Endokrinologie Hanover, Germany
Clinical trial condition
Cholangiocarcinoma Non-resectable
Explore clinical trials studying Cholangiocarcinoma Non-resectable. Study availability and eligibility vary by location and protocol.
13 public trials
5 recruiting studies
Cholangiocarcinoma Non-resectable trial results
NCT03043547
- Conditions
- Cholangiocarcinoma Advanced, Cholangiocarcinoma Metastatic, Cholangiocarcinoma Non-resectable, +1 more
- Locations
-
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover Hanover, Germany
Active, Not Recruiting
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06081829
- Conditions
- Cholangiocarcinoma Metastatic, Cholangiocarcinoma Non-resectable
- Locations
-
- National Cancer Center Hospital East (JPN-002) Kashiwa, Japan
- Kumamoto University Hospital (JPN-004) Kumamoto, Japan
- National Hospital Organization Shikoku Cancer Center (JPN-007) Matsuyama, Japan
- Osaka International Cancer Institute (JPN-005) Osaka, Japan